Clinical trial
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary Incontinence After Pelvic Floor Reconstruction Surgery: A Case-Control Study
NCT07601282 is registered in ClinicalTrials.gov with Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development and Validation of a Risk Prediction Model for De Novo Stress Urinary Incontinence After Pelvic Floor Reconstruction Surgery: A Case-Control Study
- Lead sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 382 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pelvic organ prolapse (pop), stress urinary incontinence (sui)